CDKAL1 gene rs7756992 A/G polymorphism and type 2 diabetes mellitus: A meta-analysis of 62,567 subjects

Scientific Reports

Volumn 3, Issue , 2013, Pages

  Li, Yan Yan ^a   Wang, Lian Sheng ^a   Lu, Xin Zheng ^a   Yang, Zhi Jian ^a   Wang, Xiang Ming ^a   Zhou, Chuan Wei ^a   Xu, Jian ^a   Qian, Yun ^a   Chen, Ai Ling ^a  

^a THE FIRST AFFILIATED HOSPITAL OF NANJING MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CDKAL1 PROTEIN, HUMAN; CYCLIN DEPENDENT KINASE 5;

ALLELE; DIABETES MELLITUS, TYPE 2; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC PREDISPOSITION; GENETICS; GENOTYPE; HUMAN; META ANALYSIS; RISK; SINGLE NUCLEOTIDE POLYMORPHISM;

ALLELES; CYCLIN-DEPENDENT KINASE 5; DIABETES MELLITUS, TYPE 2; GENE FREQUENCY; GENETIC ASSOCIATION STUDIES; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; ODDS RATIO; POLYMORPHISM, SINGLE NUCLEOTIDE;

EID: 84889264136     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep03131     Document Type: Article

References (30)

1. Whiting, D. R., Guariguata, L., Weil, C. & Shaw, J. IDF diabetes atlas: global estimates of the prevalence of diabetes for 2011 and 2030. Diabetes Res Clin Pract 94, 311-21 (2011).
2. Yang, W. et al. Prevalence of diabetes among men and women in China. N Engl J Med 362, 1090-101 (2010).
3. Shen, H. B. et al. An epidemiological study on genetic agent in type 2 diabetes mellitus. China Public Health 15, 492-4 (1999).
4. Scott, L. J. et al. A genome-wide association study of type 2 diabetes in Finns detects multiple susceptibility variants. Science 316, 1341-5 (2007).
5. Li, H. et al. A genome-wide association study identifies GRK5 and RASGRP1 as type 2 diabetes loci in Chinese Hans. Diabetes 62, 291-8 (2013).
6. Steinthorsdottir, V. et al. A variant in CDKAL1 influences insulin response and risk of type 2 diabetes. Nat Genet 39, 770-5 (2007). (Pubitemid 46848592)
7. Pierrel, F., Douki, T., Fontecave, M. & Atta, M. MiaB protein is a bifunctional radical-S-adenosylmethionine enzyme involved in thiolation and methylation of tRNA. J Biol Chem 279, 47555-63 (2004).
8. Wei, F. Y. et al. Deficit of tRNA(Lys) modification by Cdkal1 causes the development of type 2 diabetes in mice. J Clin Invest 121, 3598-608 (2011).
9. Chistiakov, D. A. et al. The carriage of risk variants of CDKAL1 impairs beta-cell function in both diabetic and non-diabetic patients and reduces response to nonsulfonylurea and sulfonylurea agonists of the pancreatic KATP channel. Acta Diabetol 48, 227-35 (2011).
10. Li, W. et al. Association analysis of CDKAL1 rs7756992 polymorphism with the clinical characteristics and susceptibility. Journal of Wenzhou Medical College 43, 141-6 (2013).
11. Horikoshi, M. et al. Variations in the HHEX gene are associated with increased risk of type 2 diabetes in the Japanese population. Diabetologia 50, 2461-6 (2007).
12. Xu, M. et al. Combined effects of 19 common variations on type 2 diabetes in Chinese: results from two community-based studies. PLoS One 5, e14022 (2010).
13. Omori, S. et al. Association of CDKAL1, IGF2BP2, CDKN2A/B, HHEX, SLC30A8, and KCNJ11 with susceptibility to type 2 diabetes in a Japanese population. Diabetes 57, 791-5 (2008).
14. Cauchi, S. et al. Post genome-wide association studies of novel genes associated with type 2 diabetes show gene-gene interaction and high predictive value. PLoS One 3, e2031 (2008).
15. Liu, Y. et al. Positive association between variations in CDKAL1 and type 2 diabetes in Han Chinese individuals. Diabetologia 51, 2134-7 (2008).
16. Ng, M. C. et al. Implication of genetic variants near TCF7L2, SLC30A8, HHEX, CDKAL1, CDKN2A/B, IGF2BP2, and FTO in type 2 diabetes and obesity in 6,719 Asians. Diabetes 57, 2226-33 (2008).
17. Horikawa, Y. et al. Replication of genome-wide association studies of type 2 diabetes susceptibility in Japan. J Clin Endocrinol Metab 93, 3136-41 (2008).
18. Rong, R. et al. Association analysis of variation in/near FTO, CDKAL1, SLC30A8, HHEX, EXT2, IGF2BP2, LOC387761, and CDKN2B with type 2 diabetes and related quantitative traits in Pima Indians. Diabetes 58, 478-88 (2009).
19. Takeuchi, F. et al. Confirmation of multiple risk Loci and genetic impacts by a genome-wide association study of type 2 diabetes in the Japanese population. Diabetes 58, 1690-9 (2009).
20. Tabara, Y. et al. Replication study of candidate genes associated with type 2 diabetes based on genome-wide screening. Diabetes 58, 493-8 (2009).
21. Lu, F. et al. Genetic variants on chromosome 6p21.1 and 6p22.3 are associated with type 2 diabetes risk: a case-control study in Han Chinese. J Hum Genet 57, 320-5 (2012).
22. Ching, Y. P., Leong, V. Y., Wong, C. M. & Kung, H. F. Identification of an autoinhibitory domain of p21-activated protein kinase 5. J Biol Chem 278, 33621-4 (2003).
23. Ubeda, M., Rukstalis, J. M. & Habener, J. F. Inhibition of cyclin-dependent kinase 5 activity protects pancreatic beta cells from glucotoxicity. J Biol Chem 281, 28858-64 (2006).
24. Wei, F. Y. et al. Cdk5-dependent regulation of glucose-stimulated insulin secretion. Nat Med 11, 1104-8 (2005).
25. Ohara-Imaizumi, M. et al. Deletion of CDKAL1 affects mitochondrial ATP generation and first-phase insulin exocytosis. PLoS One 5, e15553 (2010).
26. Li, Y. Y. ENPP1 K121Q polymorphism and type 2 diabetes mellitus in the Chinese population: a meta-analysis including 11,855 subjects. Metabolism 61, 625-33 (2012).
27. Cochran, W. G. The effectiveness of adjustment by subclassification in removing bias in observational studies. Biometrics 24, 295-313 (1968).
28. DerSimonian, R. & Laird, N. Meta-analysis in clinical trials. Control Clin Trials 7, 177-88 (1986). (Pubitemid 17189972)
29. Mantel, N. & Haenszel, W. Statistical aspects of the analysis of data from retrospective studies of disease. J Natl Cancer Inst 22, 719-48 (1959).
30. Egger, M., Davey, Smith G., Schneider, M. & Minder, C. Bias in meta-analysis detected by a simple, graphical test. British Medical Journal 315, 629-34 (1997). (Pubitemid 27387172)